<iframe src="//www.googletagmanager.com/ns.html?id=GTM-K799DP4&l=dataLayer" height="0" width="0" style="display:none;visibility:hidden"></iframe>
NYSE:BHVN (USA) Also Trade In: Germany

Biohaven Pharmaceutical Holding Co Ltd $ 47.02 0.93 (2.02%)

Volume:
231,223
Avg Vol (1m):
681,325
Market Cap $:
2.48 Bil
Enterprise Value $:
2.02 Bil
P/E (TTM):
0.00
P/B:
11.54
Warning! GuruFocus has detected 1 Severe warning sign with BHVN. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 1Y (-%)

Financial Strength

5.2/10
Current Vs Industry Vs History
Cash-To-Debt No Debt
Piotroski F-Score 2
0
1
2
3
4
5
6
7
8
9

Profitability

2/10
Current Vs Industry Vs History
ROE % -314.51
ROA % -133.38
ROC (Joel Greenblatt) % -6129.23
3-Year EBITDA Growth Rate -96.5
N/A
3-Year EPS without NRI Growth Rate -100
N/A

Ratios

Current Vs Industry Vs History
PB Ratio 11.54
EV-to-EBIT -5.56
N/A
EV-to-EBITDA -5.56
N/A
Current Ratio 10.62
Quick Ratio 10.62

Dividend & Buy Back

Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -44.1
N/A

Valuation & Return

Current Vs Industry Vs History
Price-to-Tangible-Book 11.53
Earnings Yield (Greenblatt) % -17.91